Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients

A double-blind placebo-controlled crossover trial

Hakki Gokbel, Suleyman Turk, Nilsel Okudan, Huseyin Atalay, Muaz Belviranli, Abduzhappar Gaipov, Yalcin Solak

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Coenzyme Q10 (CoQ10) supplementation has been shown to decrease oxidative stress in a number of clinical settings. However, there are mixed results regarding the role of CoQ10 supplementation on exercise performance. Chronic kidney disease is recognized as an inflammatory state, and hemodialysis patients have low level of exercise performance. We aimed to evaluate the effect of CoQ10 supplementation on oxidative stress markers and exercise performance measures. This was a prospective, doubleblind, placebo-controlled, crossover study in which all patients received placebo and oral CoQ10 200 mg/d. Participants underwent 6-minute walking test and cycle ergometer. Blood samples were drawn to determine malondialdehyde, oxidized low-density lipoprotein, superoxide dismutase, and glutathione peroxidase. Walking distance in 6-minute walking test and estimated maximal oxygen consumption (VO2max) were recorded. Twenty-eight patients were randomized, but 23 patients completed the study protocol. Serum CoQ10 level significantly increased with supplementation compared with basal values (P , 0.05). Neither walking distance nor estimated VO2max was different between the placebo and CoQ10 groups (P . 0.05). Serum malondialdehyde levels significantly increased in both groups compared with baseline values just after the exercise (P , 0.05). There was no difference in markers of oxidative stress and antioxidant system between placebo and CoQ10 supplementation with exercise (P . 0.05). The results of this study showed no significant effect of CoQ10 supplementation on exercise performance measures and oxidative system markers compared with placebo in maintenance hemodialysis patients.

Original languageEnglish
Pages (from-to)e1736-e1743
JournalAmerican Journal of Therapeutics
Volume23
Issue number6
DOIs
Publication statusPublished - Nov 28 2016
Externally publishedYes

Fingerprint

coenzyme Q10
Cross-Over Studies
Renal Dialysis
Oxidative Stress
Placebos
Exercise
Walking
Malondialdehyde
Glutathione Peroxidase
Serum
Chronic Renal Insufficiency

Keywords

  • Coenzyme Q10
  • Exercise
  • Hemodialysis
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients : A double-blind placebo-controlled crossover trial. / Gokbel, Hakki; Turk, Suleyman; Okudan, Nilsel; Atalay, Huseyin; Belviranli, Muaz; Gaipov, Abduzhappar; Solak, Yalcin.

In: American Journal of Therapeutics, Vol. 23, No. 6, 28.11.2016, p. e1736-e1743.

Research output: Contribution to journalArticle

Gokbel, Hakki ; Turk, Suleyman ; Okudan, Nilsel ; Atalay, Huseyin ; Belviranli, Muaz ; Gaipov, Abduzhappar ; Solak, Yalcin. / Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients : A double-blind placebo-controlled crossover trial. In: American Journal of Therapeutics. 2016 ; Vol. 23, No. 6. pp. e1736-e1743.
@article{4e42397c6b1c4fc1ae87cb6fddf29d0a,
title = "Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients: A double-blind placebo-controlled crossover trial",
abstract = "Coenzyme Q10 (CoQ10) supplementation has been shown to decrease oxidative stress in a number of clinical settings. However, there are mixed results regarding the role of CoQ10 supplementation on exercise performance. Chronic kidney disease is recognized as an inflammatory state, and hemodialysis patients have low level of exercise performance. We aimed to evaluate the effect of CoQ10 supplementation on oxidative stress markers and exercise performance measures. This was a prospective, doubleblind, placebo-controlled, crossover study in which all patients received placebo and oral CoQ10 200 mg/d. Participants underwent 6-minute walking test and cycle ergometer. Blood samples were drawn to determine malondialdehyde, oxidized low-density lipoprotein, superoxide dismutase, and glutathione peroxidase. Walking distance in 6-minute walking test and estimated maximal oxygen consumption (VO2max) were recorded. Twenty-eight patients were randomized, but 23 patients completed the study protocol. Serum CoQ10 level significantly increased with supplementation compared with basal values (P , 0.05). Neither walking distance nor estimated VO2max was different between the placebo and CoQ10 groups (P . 0.05). Serum malondialdehyde levels significantly increased in both groups compared with baseline values just after the exercise (P , 0.05). There was no difference in markers of oxidative stress and antioxidant system between placebo and CoQ10 supplementation with exercise (P . 0.05). The results of this study showed no significant effect of CoQ10 supplementation on exercise performance measures and oxidative system markers compared with placebo in maintenance hemodialysis patients.",
keywords = "Coenzyme Q10, Exercise, Hemodialysis, Oxidative stress",
author = "Hakki Gokbel and Suleyman Turk and Nilsel Okudan and Huseyin Atalay and Muaz Belviranli and Abduzhappar Gaipov and Yalcin Solak",
year = "2016",
month = "11",
day = "28",
doi = "10.1097/MJT.0000000000000166",
language = "English",
volume = "23",
pages = "e1736--e1743",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Effects of coenzyme q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients

T2 - A double-blind placebo-controlled crossover trial

AU - Gokbel, Hakki

AU - Turk, Suleyman

AU - Okudan, Nilsel

AU - Atalay, Huseyin

AU - Belviranli, Muaz

AU - Gaipov, Abduzhappar

AU - Solak, Yalcin

PY - 2016/11/28

Y1 - 2016/11/28

N2 - Coenzyme Q10 (CoQ10) supplementation has been shown to decrease oxidative stress in a number of clinical settings. However, there are mixed results regarding the role of CoQ10 supplementation on exercise performance. Chronic kidney disease is recognized as an inflammatory state, and hemodialysis patients have low level of exercise performance. We aimed to evaluate the effect of CoQ10 supplementation on oxidative stress markers and exercise performance measures. This was a prospective, doubleblind, placebo-controlled, crossover study in which all patients received placebo and oral CoQ10 200 mg/d. Participants underwent 6-minute walking test and cycle ergometer. Blood samples were drawn to determine malondialdehyde, oxidized low-density lipoprotein, superoxide dismutase, and glutathione peroxidase. Walking distance in 6-minute walking test and estimated maximal oxygen consumption (VO2max) were recorded. Twenty-eight patients were randomized, but 23 patients completed the study protocol. Serum CoQ10 level significantly increased with supplementation compared with basal values (P , 0.05). Neither walking distance nor estimated VO2max was different between the placebo and CoQ10 groups (P . 0.05). Serum malondialdehyde levels significantly increased in both groups compared with baseline values just after the exercise (P , 0.05). There was no difference in markers of oxidative stress and antioxidant system between placebo and CoQ10 supplementation with exercise (P . 0.05). The results of this study showed no significant effect of CoQ10 supplementation on exercise performance measures and oxidative system markers compared with placebo in maintenance hemodialysis patients.

AB - Coenzyme Q10 (CoQ10) supplementation has been shown to decrease oxidative stress in a number of clinical settings. However, there are mixed results regarding the role of CoQ10 supplementation on exercise performance. Chronic kidney disease is recognized as an inflammatory state, and hemodialysis patients have low level of exercise performance. We aimed to evaluate the effect of CoQ10 supplementation on oxidative stress markers and exercise performance measures. This was a prospective, doubleblind, placebo-controlled, crossover study in which all patients received placebo and oral CoQ10 200 mg/d. Participants underwent 6-minute walking test and cycle ergometer. Blood samples were drawn to determine malondialdehyde, oxidized low-density lipoprotein, superoxide dismutase, and glutathione peroxidase. Walking distance in 6-minute walking test and estimated maximal oxygen consumption (VO2max) were recorded. Twenty-eight patients were randomized, but 23 patients completed the study protocol. Serum CoQ10 level significantly increased with supplementation compared with basal values (P , 0.05). Neither walking distance nor estimated VO2max was different between the placebo and CoQ10 groups (P . 0.05). Serum malondialdehyde levels significantly increased in both groups compared with baseline values just after the exercise (P , 0.05). There was no difference in markers of oxidative stress and antioxidant system between placebo and CoQ10 supplementation with exercise (P . 0.05). The results of this study showed no significant effect of CoQ10 supplementation on exercise performance measures and oxidative system markers compared with placebo in maintenance hemodialysis patients.

KW - Coenzyme Q10

KW - Exercise

KW - Hemodialysis

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84995813050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995813050&partnerID=8YFLogxK

U2 - 10.1097/MJT.0000000000000166

DO - 10.1097/MJT.0000000000000166

M3 - Article

VL - 23

SP - e1736-e1743

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 6

ER -